| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA993: Burosumab for treating X-linked hypophosphataemia in adults |
|
Medicine details |
|
| Medicine name | burosumab (Crysvita®) |
| Formulation | 10 mg, 20 mg and 30 mg solution for injection |
| Reference number | 4367 |
| Indication | Treatment of X-linked hypophosphataemia in adults |
| Company | Kyowa Kirin Ltd |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 13/05/2021 |
| NICE guidance | TA993: Burosumab for treating X-linked hypophosphataemia in adults |